Abstract
This Special Section constitutes an expansion of the results of the NIMH Research Units on Pediatric Psychopharmacology (RUPP) efforts related to its multisite treatment study of fluvoxamine in children with anxiety disorders (Research Unit on Pediatric Psychopharmacology Anxiety Study Group, 2002). In the RUPP anxiety disorders study, 128 children with social phobia, separation anxiety disorder, or generalized anxiety disorder were randomly assigned to placebo or fluvoxamine treatment in an 8-week, double-blind, parallel trial.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
